Data / Form D filings / Incyclix Bio, LLC
Incyclix Bio, LLC: Form D filings
Incyclix Bio, LLC, a pharmaceuticals company in Durham, NC, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on August 22, 2025, reports $11.2 million sold of a $20 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 600 PARK OFFICES DRIVE, Suite 355, Durham, NC, 27713
- Phone
- (919) 328-0003
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1916275
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | New notice | $20,000,000 | $11,249,977 | $8,750,023 | 4 | Aug 6, 2025 | sec.gov |
| Jul 6, 2023 | Amendment | $29,999,931 | $14,952,930 | $15,047,001 | 5 | Feb 22, 2022 | sec.gov |
| Mar 31, 2022 | New notice | $29,999,917 | $11,999,940 | $17,999,977 | 5 | Feb 22, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Norman N. Sharpless | Director | |
| Fredric N. Eshelman | Executive Officer, Director | |
| Patrick Roberts | Executive Officer, Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Aug 18, 2025 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Incyclix Bio, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.